Ken Griffin acquired 300 Theravance Biopharma shares worth $2.69 Thousand. That's 0.00% of their equity portfolio (4624th largest holding). The first Theravance Biopharma trade was made in Q2 2014. Since then Ken Griffin bought shares 31 more times and sold shares on 36 occasions. The investor's estimated purchase price is $2.77 Thousand, resulting in a loss of 2.7%.